Phibro Animal Health Corporation (PAHC)
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 34.5309
- Book/Share 7.6894
- PB 5.8951
- Debt/Equity 1.9556
- CurrentRatio 3.094
- ROIC 0.0925
- MktCap 1837415921.0
- FreeCF/Share 0.8459
- PFCF 53.5877
- PE 27.094
- Debt/Assets 0.4399
- DivYield 0.0106
- ROE 0.2443
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PAHC | JP Morgan | Neutral | Overweight | -- | $35 | July 7, 2025 |
| Upgrade | PAHC | BNP Paribas Exane | Underperform | Neutral | -- | $24 | June 16, 2025 |
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript
Published: November 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Phibro Animal Health Corporation ( PAHC ) Q1 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman, President & CEO Larry Miller - Chief Operating Officer Daniel Bendheim - Executive VP of Corporate Strategy & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Presentation Operator Hello, and thank you for standing by. Welcome to the Phibro Animal Health Corporation First Quarter 2026 Webcast and Conference Call.
Read More
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs
Published: October 30, 2025 by: Business Wire
Sentiment: Neutral
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation is proud to announce the national launch of Restoris™ piezoelectric dental gel, a revolutionary dental gel designed to treat and support long-term oral health in dogs with periodontal disease. Developed in collaboration with a leading U.S. dental school and licensed to Phibro, Restoris represents a breakthrough in veterinary dental care, offering a dual mechanism of action to restore oral health at its foundation. The launch of Re.
Read More
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Read More
New Strong Buy Stocks for September 30th
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive
UGP, PDS, FUTU, PAHC and PGY have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2025.
Read More
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It?
Published: September 25, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC rallies 82% YTD with booming vaccines, MFAs and global expansion fueling investor confidence.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock
Published: September 22, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Phibro Animal Health (PAHC) Is Up 0.43% in One Week: What You Should Know
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
Published: September 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.
Read More
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
Published: September 02, 2025 by: Seeking Alpha
Sentiment: Positive
Phibro Animal Health Corporation's Zoetis MFA acquisition has revitalized its overall growth. Animal Health is now around 75% of their total sales, and its integration should be finalized by Q4 2025. Post-integration, PAHC believes Zoetis MFAs will normalize to flat growth. But, Vaccines and Nutritional Specialties should continue growing at double digits. PAHC's Phibro Forward initiative is also adding new efficiencies in procurement, commercial, and process improvements.
Read More
Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript
Published: August 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2025 Earnings Conference August 28, 2025 9:00 AM ET Company Participants Daniel M. Bendheim - Executive VP of Corporate Strategy & Director Glenn C.
Read More
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro Animal Health posts strong Q4 earnings and revenues, fueled by Animal Health growth. Meanwhile, the gross margin contracts.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Best Growth Stocks to Buy for July 23rd
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC, AFYA and ROAD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 23, 2025.
Read More
Best Value Stocks to Buy for July 23rd
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
NX, OPBK and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2025.
Read More
Best Growth Stocks to Buy for July 17th
Published: July 17, 2025 by: Zacks Investment Research
Sentiment: Positive
QFIN, AFYA and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 17, 2025.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Best Growth Stocks to Buy for July 10th
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
GOOS, PAHC and DELL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 10, 2025.
Read More
Invest in 4 Winning Stocks With Proven Relative Price Power
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
DELL, JBL, PAHC, and HBM are showing strong relative price strength and upward earnings estimates amid a rising market.
Read More
Best Growth Stocks to Buy for July 8th
Published: July 08, 2025 by: Zacks Investment Research
Sentiment: Positive
STRT, PAHC and AFYA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 8, 2025.
Read More
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost
Published: July 07, 2025 by: Benzinga
Sentiment: Positive
JPMorgan upgraded Phibro Animal Health Corporation PAHC, citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.
Read More
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue?
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Jack Clifford Bendheim
- Employees 1940